P140Cap activators belong to a specialized and intricate class of chemical compounds that primarily interact with and modulate the function of a specific cellular protein known as p140Cap. This protein, which is encoded by the gene SRCIN1 (SRC kinase signaling inhibitor 1), has a significant role in various cellular processes due to its ability to act as a scaffold. As a scaffold protein, p140Cap is involved in the assembly of multi-protein complexes, which are critical for the propagation of intracellular signals. The chemical activators of p140Cap are designed to bind to and enhance the function of this protein, thereby influencing the complexes it helps to form and the subsequent signaling cascades. These signaling pathways are essential for numerous cellular functions, including the regulation of cytoskeletal dynamics, which are fundamental to cell shape, motility, and adhesion.
The molecular design of p140Cap activators is centered around their ability to engage with the protein at specific sites, which is crucial for their modulatory role. These activators are often the result of targeted drug design, employing computational and biophysical methods to ensure specificity and efficacy in their interaction with p140Cap. The activators may mimic natural ligands or may be entirely synthetic entities crafted to fit into the protein's active or allosteric sites, where they can exert their modulatory effects. By binding to p140Cap, these compounds can potentially influence the protein's conformation, stability, and its association with other cellular components. The precise nature of these interactions is dependent on the chemical structure of the activator, which is often characterized by a degree of complexity to allow for the specificity of the binding event.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor; affecting protein stability and degradation mechanisms, potentially influencing p140Cap. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, potentially influencing cellular processes and pathways that p140Cap is involved in. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated kinase inhibitor; can modulate cytoskeleton dynamics, potentially influencing p140Cap activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; given the interplay of mTOR signaling and actin dynamics, Rapamycin can indirectly influence p140Cap. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator; as PKC can influence several cellular pathways, it may have downstream effects on p140Cap. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore; by altering calcium levels, it can modulate cellular pathways potentially linked to p140Cap. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule depolymerizing agent; by affecting cytoskeleton, it may have indirect effects on p140Cap dynamics. | ||||||